Call Options Transactions Made in Q2 2024 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q2 2024. The information is specifically focused on institutions that hold call options of NEUROCRINE BIOSCIENCES INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
108KNew |
$14.1M - $15.4M
|
108K
$15.4M
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
BUY
|
CALL |
60KNew |
$7.85M - $8.59M
|
60K
$8.6M
|
|
Aug 14, 2024
Q2 2024
|
Lmr Partners LLP
London, X0 |
BUY
|
CALL |
50.3K+ 31.15% |
$6.58M - $7.2M
|
212K
$30.3M
|
|
Aug 14, 2024
Q2 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
30.3KNew |
$3.97M - $4.34M
|
30.3K
$4.34M
|
|
Aug 14, 2024
Q2 2024
|
Nomura Holdings Inc
Tokyo, M0 |
BUY
|
CALL |
16.8KNew |
$2.2M - $2.41M
|
16.8K
$2.41M
|
|
Aug 14, 2024
Q2 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
15KNew |
$1.96M - $2.15M
|
15K
$2.15M
|
|
Aug 14, 2024
Q2 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
1.8K+ 47.37% |
$236K - $258K
|
5.6K
$802K
|
|
Aug 14, 2024
Q2 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
1KNew |
$131K - $143K
|
1K
$143K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-2.7K- 6.92% |
$353K - $387K
|
36.3K
$5.2M
|
|
Aug 14, 2024
Q2 2024
|
Gts Securities LLC
New York, NY |
SELL
|
CALL |
-2.9K- 37.18% |
$379K - $415K
|
4.9K
$702K
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-15.2K- 8.45% |
$1.99M - $2.18M
|
165K
$23.6M
|
|
Aug 13, 2024
Q2 2024
|
Peak6 Investments LLC
Chicago, IL |
SELL
|
CALL |
-17.5K- 95.11% |
$2.29M - $2.51M
|
900
$129K
|
|
Aug 14, 2024
Q2 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-18.2K- 74.9% |
$2.38M - $2.61M
|
6.1K
$874K
|